Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02260505
Title Efficiency of Imatinib Treatment Maintenance or Interruption After 3 Years of Adjuvant Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (ImadGist)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Centre Leon Berard
Indications

gastrointestinal stromal tumor

Therapies

Imatinib

Age Groups: adult | senior
Covered Countries

Additional content available in CKB BOOST